Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
- Status
- COMPLETED
- Phase
- N/A
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2
Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
- Status
- COMPLETED
- Phase
- PHASE2
Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas
- Status
- COMPLETED
- Phase
- PHASE3
Subcutaneous Amifostine Safety Study
- Status
- COMPLETED
- Phase
- PHASE4
A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities
- Status
- COMPLETED
- Phase
- NA
Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- N/A
Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2